Wednesday, March 29, 2023


Biotechnology News Magazine

John Tourlas Appointed President of Medicom’s North American Business Unit: Effective January 4

Latest Posts

Risk From Pharma Reps Using Unapproved Content and Messaging in the Field Persists, but a Focus on Training Could Be the Answer

ACTO advises Study Reveals 50% of respondents in leadership roles catch incidents of field reps using unapproved content, but a continuous learning culture could eliminate this behavior.

Entrinsic Bioscience® Expands enterade® Brand with Innovative Approach to the Dietary Support of Irritable Bowel Syndrome with Diarrhea (IBS-D

enterade® IBS-D is the first medical food formulated with plant-based amino acids and electrolytes for Irritable Bowel Syndrome with Diarrhea (IBS-D)-

Russell Finex Helps Leading Pharmaceutical Company Meet High Levels Of Demand With The Russell Compact Sieve

To ensure the highest quality final product, the company reached out to Russell Finex for a high-capacity vibrating screen. After assessing the company’s requirements, Russell Finex recommended the Russell Compact Sieve® as the ideal solution for check-screening pharmaceutical powders due to its stainless-steel contact parts, and easy-to-clean strip down design.

How Biotech Businesses Can Benefit from Freelance Experts

Ashmita Das, CEO of open talent platform Kolabtree, shares some of Kolabtree freelancer’s success stories.

January 25, 2021

John Tourlas has been appointed President of Medicom’s North American Business Unit.

John Tourlas is a seasoned leader with 30 years of experience and extensive strategic and operational expertise in international business management. Over the course of his career, his in-depth knowledge of the manufacturing and distribution business model has produced multiple financial and operational success stories.

Until recently, Mr. Tourlas served as Global Vice President and General Manager of the Laboratory Products Division of Thermo Fisher Scientific, a long-time Medicom customer. In this capacity, he oversaw six global manufacturing sites, managed a leadership team of eleven and gained a solid understanding of the competitive landscape, suppliers and customers. Originally from Montreal, this is a return to his roots for Mr. Tourlas.

Mr. Tourlas will lead Medicom’s entire North American business unit and assist in the development of ongoing strategies and tactics across all activities, channels and products. He will help the organization achieve its short and long-term goals, influence the direction of the business and contribute to the development of world-class operational and commercial structures.

Commenting on the appointment, Ronald Reuben, Medicom Chief Executive Officer, said, “John’s knowledge of our industry, our management team and our overall strategic direction will enable him to quickly integrate into his new role. This is an important advantage, as Medicom is growing faster than ever to meet the exponential demand for personal protective equipment and other infection control products due to the COVID-19 pandemic.”

Following Mr. Tourlas’ appointment and integration, Guillaume Laverdure will refocus on his role as Chief Operating Officer of the Medicom Group, leading the expansion of production facilities worldwide, and Ouriel Levy will focus on his role as Global President of the Dental Division and assume greater responsibility at the Group level.


Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine